{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:47:14Z","timestamp":1769024834120,"version":"3.49.0"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":50,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012371","name":"Faculty of Science and Engineering, University of Manchester","doi-asserted-by":"publisher","award":["DL57\/2016\/CP1334\/CT0006"],"award-info":[{"award-number":["DL57\/2016\/CP1334\/CT0006"]}],"id":[{"id":"10.13039\/100012371","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012371","name":"Faculty of Science and Engineering, University of Manchester","doi-asserted-by":"publisher","award":["SFRH\/BD\/138202\/2018"],"award-info":[{"award-number":["SFRH\/BD\/138202\/2018"]}],"id":[{"id":"10.13039\/100012371","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012371","name":"Faculty of Science and Engineering, University of Manchester","doi-asserted-by":"publisher","award":["SFRH\/BHD\/110001\/2015"],"award-info":[{"award-number":["SFRH\/BHD\/110001\/2015"]}],"id":[{"id":"10.13039\/100012371","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["LA\/P\/0140\/2020"],"award-info":[{"award-number":["LA\/P\/0140\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/04378\/2020"],"award-info":[{"award-number":["UIDB\/04378\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/04378\/2020"],"award-info":[{"award-number":["UIDP\/04378\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.metabol.2022.155250","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T18:57:03Z","timestamp":1657133823000},"page":"155250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Insights on the molecular targets of cardiotoxicity induced by anticancer drugs: A systematic review based on proteomic findings"],"prefix":"10.1016","volume":"134","author":[{"given":"Sofia Reis","family":"Brand\u00e3o","sequence":"first","affiliation":[]},{"given":"F\u00e9lix","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Amado","sequence":"additional","affiliation":[]},{"given":"Rita","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Vera Marisa","family":"Costa","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2022.155250_bb0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/21548331.2018.1530831","article-title":"Cardiotoxicity of cancer chemotherapy in clinical practice","volume":"47","author":"Jain","year":"2019","journal-title":"Hosp Pract"},{"key":"10.1016\/j.metabol.2022.155250_bb0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/CRD.0000000000000194","article-title":"Cardioprotection in the modern era of cancer chemotherapy","volume":"26","author":"Godishala","year":"2018","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.metabol.2022.155250_bb0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5301\/tj.5000387","article-title":"Major contributions towards finding a cure for cancer through chemotherapy: a historical review","volume":"102","author":"Masood","year":"2016","journal-title":"Tumori J"},{"key":"10.1016\/j.metabol.2022.155250_bb0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1517\/14740338.4.2.219","article-title":"Toxicity of the topoisomerase II inhibitors","volume":"4","author":"Seiter","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.metabol.2022.155250_bb0025","first-page":"309","article-title":"Cardiotoxicity of anticancer treatments: epidemiology, detection, and management: cardiotoxicity of anticancer treatments","volume":"66","author":"Curigliano","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.metabol.2022.155250_bb0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/07388558509150782","article-title":"Anthracycline antibiotics","volume":"3","author":"Fujiwara","year":"1985","journal-title":"Crit Rev Biotechnol"},{"key":"10.1016\/j.metabol.2022.155250_bb0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1470-2045(05)70094-2","article-title":"Docetaxel for treatment of solid tumours: a systematic review of clinical data","volume":"6","author":"Montero","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.metabol.2022.155250_bb0040","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1182\/blood.V97.3.631","article-title":"Melphalan and purine analog\u2013containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation","volume":"97","author":"Giralt","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.metabol.2022.155250_bb0045","first-page":"CD004706","article-title":"Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer","volume":"Issue 12. Art. No","author":"Lawrie","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.metabol.2022.155250_bb0050","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/clc.20904","article-title":"Melphalan-induced supraventricular tachycardia: incidence and risk factors","volume":"34","author":"Feliz","year":"2011","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.metabol.2022.155250_bb0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.flm.2017.06.001","article-title":"Molecular targeted therapy of cancer: the progress and future prospect","volume":"1","author":"Ke","year":"2017","journal-title":"Front Lab Med"},{"key":"10.1016\/j.metabol.2022.155250_bb0060","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1038\/bcj.2014.93","article-title":"Cardiac complications in relapsed and refractory multiple myeloma patients treated with carfilzomib","volume":"5","author":"Atrash","year":"2015","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.metabol.2022.155250_bb0065","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1182\/blood-2018-06-858415","article-title":"Molecular mechanisms of carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of metformin","volume":"133","author":"Efentakis","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.metabol.2022.155250_bb0070","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nrc2106","article-title":"Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition","volume":"7","author":"Force","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.metabol.2022.155250_bb0075","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.2147\/DDDT.S119162","article-title":"Three generations of epidermal growth factor receptor tyrosine kinase inhibitors developed to revolutionize the therapy of lung cancer","volume":"10","author":"Zhang","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.metabol.2022.155250_bb0080","doi-asserted-by":"crossref","first-page":"40374","DOI":"10.1038\/srep40374","article-title":"The prognostic role of EGFR-TKIs for patients with advanced non-small cell lung cancer","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2022.155250_bb0085","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1200\/JCO.2005.16.584","article-title":"Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas","volume":"23","author":"Burris","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.metabol.2022.155250_bb0090","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/cncr.28465","volume":"120","author":"Welslau","year":"2014","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.metabol.2022.155250_bb0095","first-page":"677","article-title":"Remission of psoriasis in a patient with hepatocellular carcinoma treated with sorafenib","volume":"30","author":"Antoniou","year":"2016","journal-title":"In Vivo"},{"key":"10.1016\/j.metabol.2022.155250_bb0100","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/S0140-6736(11)61613-9","article-title":"Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial","volume":"378","author":"Rini","year":"2011","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/j.metabol.2022.155250_bb0105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2022.155250_bb0110","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(06)69446-4","article-title":"Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial","volume":"368","author":"Demetri","year":"2006","journal-title":"The Lancet"},{"key":"10.1016\/j.metabol.2022.155250_bb0115","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1200\/JCO.2003.09.081","volume":"21","author":"Citron","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.metabol.2022.155250_bb0120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0960-9776(02)00273-4","article-title":"Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 international study","volume":"12","author":"Bilous","year":"2003","journal-title":"The Breast"},{"key":"10.1016\/j.metabol.2022.155250_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119760","article-title":"An update of the molecular mechanisms underlying doxorubicin plus trastuzumab induced cardiotoxicity","volume":"280","author":"Anjos","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.metabol.2022.155250_bb0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mito.2016.07.005","article-title":"Cardiac cytochrome c and cardiolipin depletion during anthracycline-induced chronic depression of mitochondrial function","volume":"30","author":"Pereira","year":"2016","journal-title":"Mitochondrion"},{"key":"10.1016\/j.metabol.2022.155250_bb0135","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1126\/science.877547","article-title":"Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response","volume":"197","author":"Myers","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.metabol.2022.155250_bb0140","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2022.155250_bb0145","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbrc.2008.11.059","article-title":"Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs","volume":"378","author":"Ashley","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2022.155250_bb0150","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1172\/JCI72931","article-title":"Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation","volume":"124","author":"Ichikawa","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2022.155250_bb0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/1389200216666151103114926","article-title":"The role of the metabolism of anticancer drugs in their induced-cardiotoxicity","volume":"17","author":"Reis-Mendes","year":"2015","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.metabol.2022.155250_bb0160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejphar.2017.10.043","article-title":"Molecular mechanism of doxorubicin-induced cardiomyopathy - an update","volume":"818","author":"Renu","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.metabol.2022.155250_bb0165","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1021\/tx400130v","article-title":"The heart as a target for xenobiotic toxicity: the cardiac susceptibility to oxidative stress","volume":"26","author":"Costa","year":"2013","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.metabol.2022.155250_bb0170","first-page":"121","article-title":"Diagnosis of chemotherapy-induced cardiotoxicity","volume":"1","author":"Pizzino","year":"2014","journal-title":"J PatientCentered Res Rev"},{"key":"10.1016\/j.metabol.2022.155250_bb0175","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/j.seminoncol.2005.11.001","article-title":"Anticancer agents and cardiotoxicity","volume":"33","author":"Ng","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1016\/j.metabol.2022.155250_bb0180","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/HJH.0b013e32835c1d1b","article-title":"Mechanism of hypertension and proteinuria during angiogenesis inhibition: evolving role of endothelin-1","volume":"31","author":"Lankhorst","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.metabol.2022.155250_bb0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1752-8062.2008.00090.x","article-title":"Sunitinib-induced cardiotoxicity is mediated by off-target inhibition of AMP-activated protein kinase","volume":"2","author":"Kerkela","year":"2009","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.metabol.2022.155250_bb0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/toxsci\/kfn157","article-title":"Effect of the Multitargeted Tyrosine Kinase Inhibitors Imatinib, Dasatinib, Sunitinib, and Sorafenib on Mitochondrial Function in Isolated Rat Heart Mitochondria and H9c2 Cells","volume":"106","author":"Will","year":"2008","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.metabol.2022.155250_bb0195","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0140-6736(07)61865-0","article-title":"Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib","volume":"370","author":"Chu","year":"2007","journal-title":"The Lancet"},{"issue":"3","key":"10.1016\/j.metabol.2022.155250_bb0200","first-page":"70","article-title":"Trastuzumab-induced cardiac dysfunction: a \u2018dual-hit\u2019","volume":"16","author":"Zeglinski","year":"2011","journal-title":"Exp Clin Cardiol"},{"key":"10.1016\/j.metabol.2022.155250_bb0205","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2004.08.066","article-title":"Inhibition of ErbB2 causes mitochondrial dysfunction in cardiomyocytes","volume":"44","author":"Grazette","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2022.155250_bb0210","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0022-2828(03)00145-7","article-title":"NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy","volume":"35","author":"Nakagami","year":"2003","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.metabol.2022.155250_bb0215","first-page":"13","article-title":"Trastuzumab-mediated cardiotoxicity: current understanding, challenges, and frontiers","volume":"1","author":"Mohan","year":"2018","journal-title":"Antib Ther"},{"key":"10.1016\/j.metabol.2022.155250_bb0220","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/chromsci\/bmw167","article-title":"Proteomics: technologies and their applications","volume":"55","author":"Aslam","year":"2017","journal-title":"J Chromatogr Sci"},{"key":"10.1016\/j.metabol.2022.155250_bb0225","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/14789450.2016.1252676","article-title":"Toxicoproteomics in human health and disease: an update","volume":"13","author":"Suman","year":"2016","journal-title":"Expert Rev Proteomics"},{"issue":"1","key":"10.1016\/j.metabol.2022.155250_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mas.21404","article-title":"Redox proteomics: from protein modifications to cellular dysfunction and disease","volume":"33","author":"Butterfield","year":"2014","journal-title":"Mass Spectrom Rev"},{"key":"10.1016\/j.metabol.2022.155250_bb0235","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022247","article-title":"Carfilzomib treatment causes molecular and functional alterations of human induced pluripotent stem cell-derived cardiomyocytes","volume":"10","author":"Forghani","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.metabol.2022.155250_bb0240","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.yjmcc.2011.01.018","article-title":"Proteomic insights into chronic anthracycline cardiotoxicity","volume":"50","author":"\u0160t\u011brba","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.metabol.2022.155250_bb0245","doi-asserted-by":"crossref","first-page":"H1832","DOI":"10.1152\/ajpheart.01047.2009","article-title":"Role of heat shock factor-1 activation in the doxorubicin-induced heart failure in mice","volume":"298","author":"Vedam","year":"2010","journal-title":"Am J PhysiolHeart Circ Physiol"},{"key":"10.1016\/j.metabol.2022.155250_bb0250","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.freeradbiomed.2006.08.006","article-title":"Redox proteomic identification of oxidized cardiac proteins in adriamycin-treated mice","volume":"41","author":"Chen","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.metabol.2022.155250_bb0255","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.freeradbiomed.2014.03.001","article-title":"Redox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatment","volume":"72","author":"Zhao","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.metabol.2022.155250_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.152852","article-title":"Exploring the aging effect of the anticancer drugs doxorubicin and mitoxantrone on cardiac mitochondrial proteome using a murine model","volume":"459","author":"Brand\u00e3o","year":"2021","journal-title":"Toxicology"},{"key":"10.1016\/j.metabol.2022.155250_bb0265","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1111\/j.1582-4934.2011.01257.x","article-title":"Identification of protein targets underlying dietary nitrate-induced protection against doxorubicin cardiotoxicity","volume":"15","author":"Xi","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.metabol.2022.155250_bb0270","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1124\/jpet.105.089763","article-title":"Modulation of cytochrome c oxidase-va is possibly involved in metallothionein protection from doxorubicin cardiotoxicity","volume":"315","author":"Merten","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.metabol.2022.155250_bb0275","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3109\/08923970903440168","article-title":"Measuring adriamycin-induced cardiac hemodynamic dysfunction with a proteomics approach","volume":"32","author":"Cui","year":"2010","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"5","key":"10.1016\/j.metabol.2022.155250_bb0280","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jprot.2011.02.013","article-title":"Analysis of proteome changes in doxorubicin-treated adult rat cardiomyocyte","volume":"74","author":"Kumar","year":"2011","journal-title":"J Proteome"},{"key":"10.1016\/j.metabol.2022.155250_bb0285","doi-asserted-by":"crossref","first-page":"5136934","DOI":"10.1155\/2020\/5136934","article-title":"Functional redox proteomics reveal that salvia miltiorrhiza aqueous extract alleviates adriamycin-induced cardiomyopathy via inhibiting ros-dependent apoptosis","volume":"2020","author":"Hung","year":"2020","journal-title":"Oxidative Med Cell Longev"},{"key":"10.1016\/j.metabol.2022.155250_bb0290","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1016\/j.jprot.2012.02.004","article-title":"Cardiac phosphoproteome reveals cell signaling events involved in doxorubicin cardiotoxicity","volume":"75","author":"Gratia","year":"2012","journal-title":"J Proteomics"},{"key":"10.1016\/j.metabol.2022.155250_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.695625","article-title":"Translational proteomics analysis of anthracycline-induced cardiotoxicity from cardiac microtissues to human heart biopsies","volume":"12","author":"Nguyen","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.metabol.2022.155250_bb0300","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/md17010002","article-title":"Spinochrome D attenuates doxorubicin-induced cardiomyocyte death via improving glutathione metabolism and attenuating oxidative stress","volume":"17","author":"Yoon","year":"2018","journal-title":"Mar Drugs"},{"key":"10.1016\/j.metabol.2022.155250_bb0305","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/toxsci\/kfy012","article-title":"Expression profiling of human pluripotent stem cell-derived cardiomyocytes exposed to doxorubicin\u2014integration and visualization of multi-omics data","volume":"163","author":"Holmgren","year":"2018","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.metabol.2022.155250_bb0310","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.yexcr.2015.10.020","article-title":"Proteomic investigation of embryonic rat heart-derived H9c2 cell line sheds new light on the molecular phenotype of the popular cell model","volume":"339","author":"Len\u010do","year":"2015","journal-title":"Exp Cell Res"},{"issue":"1","key":"10.1016\/j.metabol.2022.155250_bb0315","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1423-0127-20-95","article-title":"Quercetin-induced cardioprotection against doxorubicin cytotoxicity","volume":"20","author":"Chen","year":"2013","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.metabol.2022.155250_bb0320","doi-asserted-by":"crossref","first-page":"H2680","DOI":"10.1152\/ajpheart.00395.2006","article-title":"Heat shock protects cardiac cells from doxorubicin-induced toxicity by activating p38 MAPK and phosphorylation of small heat shock protein 27","volume":"291","author":"Venkatakrishnan","year":"2006","journal-title":"Am J PhysiolHeart Circ Physiol"},{"key":"10.1016\/j.metabol.2022.155250_bb0325","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1039\/c2mb25367d","article-title":"Redox-proteomic analysis of doxorubicin-induced altered thiol activity in cardiomyocytes","volume":"9","author":"Lin","year":"2013","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.metabol.2022.155250_bb0330","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.bcp.2010.04.037","article-title":"A toxicoproteomic study on cardioprotective effects of pre-administration of docetaxel in a mouse model of adriamycin-induced cardiotoxicity","volume":"80","author":"Ohyama","year":"2010","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"10.1016\/j.metabol.2022.155250_bb0335","doi-asserted-by":"crossref","first-page":"e006635","DOI":"10.1161\/JAHA.117.006635","volume":"6","author":"Stuhlmiller","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.metabol.2022.155250_bb0340","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cels.2019.03.009","article-title":"Adaptation of human iPSC-derived cardiomyocytes to tyrosine kinase inhibitors reduces acute cardiotoxicity via metabolic reprogramming","volume":"8","author":"Wang","year":"2019","journal-title":"Cell Syst"},{"key":"10.1016\/j.metabol.2022.155250_bb0345","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1186\/s13287-020-01984-1","article-title":"Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells","volume":"11","author":"Liu","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.metabol.2022.155250_bb0350","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1007\/s00204-020-02874-4","article-title":"Mitoxantrone impairs proteasome activity and prompts early energetic and proteomic changes in HL-1 cardiomyocytes at clinically relevant concentrations","volume":"94","author":"Costa","year":"2020","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.metabol.2022.155250_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169964","article-title":"A novel positron emission tomography (PET) approach to monitor cardiac metabolic pathway remodeling in response to sunitinib malate","volume":"12","author":"O\u2019Farrell","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.metabol.2022.155250_bb0360","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.7150\/thno.19551","article-title":"Cardiac metabolic deregulation induced by the tyrosine kinase receptor inhibitor sunitinib is rescued by endothelin receptor antagonism","volume":"7","author":"Sourdon","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.metabol.2022.155250_bb0365","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2174\/1389201021666200515135548","article-title":"Proteomics analysis of trastuzumab toxicity in the H9c2 cardiomyoblast cell line and its inhibition by carvedilol","volume":"21","author":"Beiranvand","year":"2020","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.metabol.2022.155250_bb0370","first-page":"16","article-title":"The art of intercellular wireless communications: exosomes in heart disease and therapy","volume":"7","author":"Krishnamurthy","year":"2019","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"10.1016\/j.metabol.2022.155250_bb0375","doi-asserted-by":"crossref","first-page":"64","DOI":"10.15420\/cfr.2015.1.2.64","article-title":"Cellular communications in the heart","volume":"1","author":"Fountoulaki","year":"2015","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.metabol.2022.155250_bb0380","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.624159","article-title":"Endocytic adaptors in cardiovascular disease","volume":"8","author":"Cui","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.metabol.2022.155250_bb0385","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ymthe.2017.08.019","article-title":"Evaluation of GalNAc-siRNA conjugate activity in pre-clinical animal models with reduced asialoglycoprotein receptor expression","volume":"26","author":"Willoughby","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.metabol.2022.155250_bb0390","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jmcb\/mjy084","article-title":"News about non-secretory exocytosis: mechanisms, properties, and functions","volume":"11","author":"D\u2019Alessandro","year":"2019","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.metabol.2022.155250_bb0395","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10741-016-9532-0","article-title":"Role of cell death in the progression of heart failure","volume":"21","author":"Moe","year":"2016","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.metabol.2022.155250_bb0400","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10974-019-09539-5","article-title":"Cardiomyocyte damage control in heart failure and the role of the sarcolemma","volume":"40","author":"Kitmitto","year":"2019","journal-title":"J Muscle Res Cell Motil"},{"key":"10.1016\/j.metabol.2022.155250_bb0405","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijcard.2008.01.043","article-title":"Adriamycin-induced autophagic cardiomyocyte death plays a pathogenic role in a rat model of heart failure","volume":"134","author":"Lu","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.metabol.2022.155250_bb0410","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1074\/jbc.M109.070037","article-title":"Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death","volume":"285","author":"Kobayashi","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2022.155250_bb0415","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/CIRCRESAHA.111.248260","article-title":"Haploinsufficiency of target of rapamycin attenuates cardiomyopathies in adult zebrafish","volume":"109","author":"Ding","year":"2011","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.metabol.2022.155250_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021104","article-title":"Overexpression of Nrdp1 in the heart exacerbates doxorubicin-induced cardiac dysfunction in mice","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2022.155250_bb0425","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00441-012-1475-8","article-title":"Effects of doxorubicin cancer therapy on autophagy and the ubiquitin-proteasome system in long-term cultured adult rat cardiomyocytes","volume":"350","author":"Dimitrakis","year":"2012","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.metabol.2022.155250_bb0430","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.3390\/ijms19113658","article-title":"Ginsenoside Rg1 prevents doxorubicin-induced cardiotoxicity through the inhibition of autophagy and endoplasmic reticulum stress in mice","volume":"19","author":"Xu","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2022.155250_bb0435","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/cvr\/cvs282","article-title":"Prior starvation mitigates acute doxorubicin cardiotoxicity through restoration of autophagy in affected cardiomyocytes","volume":"96","author":"Kawaguchi","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.metabol.2022.155250_bb0440","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bcp.2012.10.005","article-title":"Autophagy upregulation promotes survival and attenuates doxorubicin-induced cardiotoxicity","volume":"85","author":"Sishi","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.metabol.2022.155250_bb0445","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1161\/CIRCULATIONAHA.115.017443","article-title":"Doxorubicin blocks cardiomyocyte autophagic flux by inhibiting lysosome acidification","volume":"133","author":"Li","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2022.155250_bb0450","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","article-title":"Cardiac metabolism in heart failure: implications beyond ATP production","volume":"113","author":"Doenst","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2022.155250_bb0455","doi-asserted-by":"crossref","first-page":"E6097","DOI":"10.1073\/pnas.1612283113","article-title":"Miro phosphorylation sites regulate Parkin recruitment and mitochondrial motility","volume":"113","author":"Shlevkov","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.metabol.2022.155250_bb0460","series-title":"Ganong's Review of Medical Physiology","year":"2018"},{"key":"10.1016\/j.metabol.2022.155250_bb0465","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.3390\/cells9122635","article-title":"Fructose metabolism in cancer","volume":"9","author":"Krause","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.metabol.2022.155250_bb0470","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbacli.2016.02.001","article-title":"Glycogen metabolism in humans","volume":"5","author":"Adeva-Andany","year":"2016","journal-title":"BBA Clin"},{"key":"10.1016\/j.metabol.2022.155250_bb0475","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.3390\/ijms20092085","article-title":"Unappreciated role of LDHA and LDHB to control apoptosis and autophagy in tumor cells","volume":"20","author":"Urba\u0144ska","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.metabol.2022.155250_bb0480","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bbadis.2011.11.017","article-title":"Molecular pathogenesis of a new glycogenosis caused by a glycogenin-1 mutation","volume":"1822","author":"Nilsson","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.metabol.2022.155250_bb0485","first-page":"112","article-title":"The role of skeletal muscle glycogen breakdown for regulation of insulin sensitivity by exercise","volume":"30","author":"Jensen","year":"2011","journal-title":"Front Physiol"},{"key":"10.1016\/j.metabol.2022.155250_bb0490","doi-asserted-by":"crossref","first-page":"lb149","DOI":"10.1096\/fasebj.31.1_supplement.lb149","article-title":"AKT signaling is essential for functional and structural integrity of the heart","volume":"31","author":"Goedecke","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2022.155250_bb0495","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","article-title":"Amino acids in cancer","volume":"52","author":"Lieu","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.metabol.2022.155250_bb0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.aquatox.2018.12.016","article-title":"The role of delta-1-pyrroline-5-carboxylate dehydrogenase (P5CDh) in the Pacific white shrimp (Litopenaeus vannamei) during biotic and abiotic stress","volume":"208","author":"Liang","year":"2019","journal-title":"Aquat Toxicol"},{"issue":"2","key":"10.1016\/j.metabol.2022.155250_bb0505","first-page":"91","article-title":"Disorders of branched chain amino acid metabolism","volume":"1","author":"Manoli","year":"2016","journal-title":"Transl Sci Rare Dis"},{"key":"10.1016\/j.metabol.2022.155250_bb0510","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ymgme.2020.04.004","article-title":"Functional analysis of thirty-four suspected pathogenic missense variants in ALDH5A1 gene associated with succinic semialdehyde dehydrogenase deficiency","volume":"130","author":"Pop","year":"2020","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.metabol.2022.155250_bb0515","doi-asserted-by":"crossref","first-page":"E1046","DOI":"10.1152\/ajpendo.00097.2018","article-title":"Cardiac branched-chain amino acid oxidation is reduced during insulin resistance in the heart","volume":"315","author":"Fillmore","year":"2018","journal-title":"Am J PhysiolEndocrinol Metab"},{"key":"10.1016\/j.metabol.2022.155250_bb0520","series-title":"Disorders of branched chain amino acid metabolism","volume":"20","author":"Manoli","year":"2016"},{"key":"10.1016\/j.metabol.2022.155250_bb0525","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1038\/s41467-021-22235-8","article-title":"Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor","volume":"12","author":"Zou","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2022.155250_bb0530","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.4155\/fmc.11.158","article-title":"Isoform-specific inhibitors of ACATs: recent advances and promising developments","volume":"3","author":"Ohshiro","year":"2011","journal-title":"Future Med Chem"},{"key":"10.1016\/j.metabol.2022.155250_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105586","article-title":"Human dehydrogenase\/reductase SDR family member 11 (DHRS11) and aldo-keto reductase 1C isoforms in comparison: substrate and reaction specificity in the reduction of 11-keto-C19-steroids","volume":"199","author":"Endo","year":"2020","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.metabol.2022.155250_bb0540","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF03194597","article-title":"The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism","volume":"47","author":"Chmurzy\u0144ska","year":"2006","journal-title":"J Appl Genet"},{"key":"10.1016\/j.metabol.2022.155250_bb0545","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1002\/elps.200405955","article-title":"Virtual two-dimensional gel electrophoresis of high-density lipoproteins","volume":"25","author":"Ogorzalek Loo","year":"2004","journal-title":"Electrophoresis"},{"key":"10.1016\/j.metabol.2022.155250_bb0550","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00018-012-1096-0","article-title":"Structure and function of biotin-dependent carboxylases","volume":"70","author":"Tong","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.metabol.2022.155250_bb0555","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.tem.2017.03.001","article-title":"Deactivating fatty acids: acyl-CoA thioesterase-mediated control of lipid metabolism","volume":"28","author":"Tillander","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2022.155250_bb0560","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fphar.2011.00024","article-title":"Prostacyclin: an inflammatory paradox","volume":"2","author":"Stitham","year":"2011","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.metabol.2022.155250_bb0565","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.bbadis.2017.07.019","article-title":"Lipid droplet proteins and metabolic diseases","volume":"1864","author":"Xu","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.metabol.2022.155250_bb0570","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s13238-017-0423-5","article-title":"Structural and functional roles of ether lipids","volume":"9","author":"Dean","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.metabol.2022.155250_bb0575","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.bbamcr.2006.08.034","article-title":"Peroxisomal \u03b2-oxidation\u2014a metabolic pathway with multiple functions","volume":"1763","author":"Poirier","year":"2006","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.metabol.2022.155250_bb0580","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10545-010-9104-8","article-title":"The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results","volume":"33","author":"Wanders","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.metabol.2022.155250_bb0585","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ymgme.2010.12.005","article-title":"Identification and characterization of new long chain Acyl-CoA dehydrogenases","volume":"102","author":"He","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.metabol.2022.155250_bb0590","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.bbamcr.2016.01.023","article-title":"Carnitine transport and fatty acid oxidation","volume":"1863","author":"Longo","year":"2016","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.metabol.2022.155250_bb0595","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1096-7192(02)00152-X","article-title":"Identification of isobutyryl-CoA dehydrogenase and its deficiency in humans","volume":"77","author":"Nguyen","year":"2002","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.metabol.2022.155250_bb0600","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-94-007-2869-1_1","article-title":"The oxidative phosphorylation system in mammalian mitochondria","volume":"942","author":"Papa","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.metabol.2022.155250_bb0605","doi-asserted-by":"crossref","first-page":"14342","DOI":"10.1073\/pnas.0707189104","article-title":"MitoNEET is a uniquely folded 2Fe\u20132S outer mitochondrial membrane protein stabilized by pioglitazone","volume":"104","author":"Paddock","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2022.155250_bb0610","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/hmg\/ddt521","article-title":"ACAD9, a complex I assembly factor with a moonlighting function in fatty acid oxidation deficiencies","volume":"23","author":"Nouws","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2022.155250_bb0615","series-title":"Textbook of Biochemistry for Medical Students","first-page":"303","article-title":"Citric acid cycle","author":"Vasudevan","year":"2016"},{"key":"10.1016\/j.metabol.2022.155250_bb0620","doi-asserted-by":"crossref","first-page":"41882","DOI":"10.1038\/srep41882","article-title":"The \u03b2 and \u03b3 subunits play distinct functional roles in the \u03b12\u03b2\u03b3 heterotetramer of human NAD-dependent isocitrate dehydrogenase","volume":"7","author":"Ma","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2022.155250_bb0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/9152732","article-title":"Reactive oxygen species: a key hallmark of cardiovascular disease","volume":"2016","author":"Panth","year":"2016","journal-title":"Adv Med"},{"key":"10.1016\/j.metabol.2022.155250_bb0630","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","article-title":"Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets","volume":"89","author":"Tham","year":"2015","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.metabol.2022.155250_bb0635","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.tiv.2018.06.013","article-title":"Influence of PARP-1 inhibition in the cardiotoxicity of the topoisomerase 2 inhibitors doxorubicin and mitoxantrone","volume":"52","author":"Damiani","year":"2018","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.metabol.2022.155250_bb0640","series-title":"Molecular Biology of the Cell","author":"Alberts","year":"2002"},{"issue":"4","key":"10.1016\/j.metabol.2022.155250_bb0645","first-page":"140","article-title":"Neddylation and deneddylation in cardiac biology","volume":"4","author":"Kandala","year":"2014","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.metabol.2022.155250_bb0650","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/pmic.200300435","article-title":"Redox proteomics: identification of oxidatively modified proteins","volume":"3","author":"Ghezzi","year":"2003","journal-title":"Proteomics"},{"key":"10.1016\/j.metabol.2022.155250_bb0655","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1074\/mcp.M300046-MCP200","article-title":"F-actin capping (CapZ) and other contractile saphenous vein smooth muscle proteins are altered by hemodynamic stress: a proteomic approach","volume":"3","author":"McGregor","year":"2004","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.metabol.2022.155250_bb0660","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1007094214460","article-title":"Adriamycin-induced heart failure: mechanisms and modulation","volume":"207","author":"Singal","year":"2000","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"10.1016\/j.metabol.2022.155250_bb0665","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1152\/physrev.00037.2019","article-title":"Role of the Epigenome in Heart Failure","volume":"100","author":"Papait","year":"2020","journal-title":"Physiol Rev"},{"key":"10.1016\/j.metabol.2022.155250_bb0670","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/227561a0","article-title":"Central dogma of molecular biology","volume":"227","author":"Crick","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2022.155250_bb0675","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrm.2017.104","article-title":"The functions and unique features of long intergenic non-coding RNA","volume":"19","author":"Ransohoff","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.metabol.2022.155250_bb0680","series-title":"Encyclopedia of Respiratory Medicine","article-title":"Signal transduction","volume":"10\u201318","author":"Torres","year":"2006"},{"key":"10.1016\/j.metabol.2022.155250_bb0685","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1124\/jpet.105.096123","article-title":"Cocaine-amphetamine-regulated transcript expression in the rat nucleus accumbens is regulated by adenylyl cyclase and the cyclic adenosine 5\u2032-monophosphate\/protein kinase a second messenger system","volume":"317","author":"Jones","year":"2006","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049522001287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049522001287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:30:50Z","timestamp":1758429050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049522001287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":137,"alternative-id":["S0026049522001287"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2022.155250","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights on the molecular targets of cardiotoxicity induced by anticancer drugs: A systematic review based on proteomic findings","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2022.155250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"155250"}}